Tammie Wahaus – As Founder, Chief Executive Officer and Board Chair, Ms. Wahaus has led the strategic planning, business development, manufacturing, regulatory and clinical trial activities of the company since 2014. Ms. Wahaus has more than 25 years of experience serving in key leadership roles in public and private companies. She joined TVAX Biomedical (an affiliate) in 2012 as Chief Financial Officer and was responsible for developing the animal health business strategy which was then spun off as ELIAS Animal Health. Previously, Ms. Wahaus was an audit partner and national office advisor with Ernst & Young LLP serving both Fortune 500 public companies and small to medium-sized private companies. She also served as Global Controller and Principal Accounting Officer for a public company, where she oversaw the global accounting and reporting operations across four continents including the integration of two international acquisitions totaling over $7 billion in assets and implemented Six Sigma Quality process management systems across the global finance operations. She is a graduate of Kansas State University (BS, Business Administration, Accounting) and serves as an advisory board member for the KSU College of Business.